Vaxxinity (NASDAQ:VAXX) Lowered to "Hold" at Zacks Investmen

Vaxxinity (NASDAQ:VAXX – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Vaxxinity Inc. is a biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. Vaxxinity Inc. is based in DALLAS, Texas. “ […]

Related Keywords

United States , Dallas , Texas , , Geode Capital Management , Goldman Sachs Group Inc , Zacks Investment Research , Investment Advisers , United Biomedical Inc , Vaxxinity Company Profile Get Rating , Managers Group , Vaxxinity Inc , Get Rating , Capital Management , Sachs Group , Adage Capital Partners , Company Profile , Lewy Body , Vaxxinity , Nasdaq Vaxx , Vaxx , Medical , Downgrade ,